Recently, Arghya Ray’s studies also demonstrated that combination of HDAC6 selective inhibitor ACY-241 and anti-PD-L1 Ab restore immune function and enhance MM cytotoxicity [59]. The gene discussed is HDAC6; the disease is Miyoshi myopathy.